| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a22000004a 4500 |
| 001 |
in00004493813 |
| 005 |
20191203081921.0 |
| 008 |
001030s2001 dcua b 001 0 eng c |
| 010 |
|
|
|a 00053111
|
| 016 |
7 |
|
|a 100969589
|2 DNLM
|
| 020 |
|
|
|a 1555811566
|
| 035 |
|
|
|a (OCoLC)ocm45276854
|
| 035 |
|
|
|z (UtOrBLW)29452
|
| 035 |
|
|
|a 44133
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 049 |
|
|
|a TMVM
|c 1
|
| 060 |
1 |
0 |
|a WC 503.2
|b A6324 2001
|
| 082 |
0 |
0 |
|a 616.97/92061
|2 21
|
| 245 |
0 |
0 |
|a Antiretroviral therapy /
|c edited by Erik D.A. de Clercq.
|
| 264 |
|
1 |
|a Washington, DC :
|b ASM Press,
|c [2001]
|
| 264 |
|
4 |
|c ©2001
|
| 300 |
|
|
|a x, 359 pages :
|b illustrations (some color) ;
|c 26 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|b txt
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|b nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
2 |
|
|a Kinetics of human immunodeficiency virus type 1 replication and therapy / Bharat Ramratnam ... [et al.] -- Cellular receptors as targets for anti-human immunodeficiency virus agents / Dominique Schols ... [et al.] -- Nucleoside and nucleotide reverse transcriptase inhibitors / J. Balzarini ... [et al.] -- Nonnucleoside reverse transcriptase inhibitors / J. Balzarini ... [et al.] -- Human immunodeficiency virus type 1 integrase-targeted inhibitor design / Nouri Neamati ... [et al.] -- Inhibitors of transcription and transactivation as anti-human immunodeficiency virus agents / Jonathan Kam -- Oligonucleotides as antiretroviral agents / A. Kirk Field -- Protease inhibitors as anti-human immunodeficiency virus agents / Dale J. Kempf ... [et al.] -- Glycoprotein processing enzymes as a target for human immunodeficiency virus chemotherapy / A. Stanley Tyms -- Cellular factors as targets for anti-human immunodeficiency virus therapy / Masanori Baba -- Therapeutic human immunodeficiency virus vaccines : concept, current status, and future directions / John S. Lambert ... [et al.] -- Clinical usefulness of human immunodeficiency virus drug resistance monitoring / Anne-Mieke Vandamme ... [et al.] -- Emergence of drug-resistant human immunodeficiency virus type 1 (HIV 1) variants and their impact on antiretroviral therapy of HIV-1 infection / Mark F. Kavlick ... [et al.] -- Combination antiretroviral therapy / Cecile Tremblay ... [et al.] -- Drug-drug interactions in human immunodeficiency virus infection / Charles W. Flexner ... [et al.]
|
| 650 |
|
2 |
|a HIV Infections
|x drug therapy.
|
| 650 |
|
2 |
|a Antiviral Agents
|x therapeutic use.
|
| 650 |
|
2 |
|a HIV Infections
|x immunology.
|
| 700 |
1 |
|
|a De Clercq, Erik.
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s b38ad047-c555-3d1c-a2c7-5b8f77c76a3a
|i 0aa35da7-27f0-3957-a31b-3951c75f6cd5
|t 0
|
| 952 |
f |
f |
|p ric
|a Texas A&M University
|b Rellis Campus
|c Joint Library Facility
|d Remote Storage
|t 0
|e WC 503.2 A6324 2001
|h National Library of Medicine classification
|i unmediated -- volume
|m 3238901268043
|
| 998 |
f |
f |
|a WC 503.2 A6324 2001
|t 0
|l Remote Storage
|